These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7565133)

  • 21. Differential recognition of Plasmodium falciparum merozoite surface protein 2 variants by antibodies from malaria patients in Brazil.
    Kanunfre KA; Leoratti FM; Hoffmann EH; Durlacher RR; Ferreira AW; Moraes-Avila SL; Ferreira MU
    Clin Diagn Lab Immunol; 2003 Sep; 10(5):973-6. PubMed ID: 12965937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seasonal changes in the antibody responses against Plasmodium falciparum merozoite surface antigens in areas of differing malaria endemicity in Indonesia.
    Supargiyono S; Bretscher MT; Wijayanti MA; Sutanto I; Nugraheni D; Rozqie R; Kosasih AA; Sulistyawati S; Hawley WA; Lobo NF; Cook J; Drakeley CJ
    Malar J; 2013 Dec; 12():444. PubMed ID: 24321092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Humoral response to defined Plasmodium falciparum antigens in cerebral and uncomplicated malaria and their relationship to parasite genotype.
    Al-Yaman F; Genton B; Reeder JC; Mokela D; Anders RF; Alpers MP
    Am J Trop Med Hyg; 1997 Apr; 56(4):430-5. PubMed ID: 9158053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural antibody responses to Plasmodium falciparum MSP3 and GLURP(R0) antigens are associated with low parasite densities in malaria patients living in the Central Region of Ghana.
    Amoah LE; Nuvor SV; Obboh EK; Acquah FK; Asare K; Singh SK; Boampong JN; Theisen M; Williamson KC
    Parasit Vectors; 2017 Aug; 10(1):395. PubMed ID: 28835262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variation in the immune responses against Plasmodium falciparum merozoite surface protein-1 and apical membrane antigen-1 in children residing in the different epidemiological strata of malaria in Cameroon.
    Kwenti TE; Moye AL; Wiylanyuy AB; Njunda LA; Nkuo-Akenji T
    Malar J; 2017 Nov; 16(1):453. PubMed ID: 29121929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Naturally acquired antibody response to a Plasmodium falciparum chimeric vaccine candidate GMZ2.6c and its components (MSP-3, GLURP, and Pfs48/45) in individuals living in Brazilian malaria-endemic areas.
    Baptista BO; de Souza ABL; Riccio EKP; Bianco-Junior C; Totino PRR; Martins da Silva JH; Theisen M; Singh SK; Amoah LE; Ribeiro-Alves M; Souza RM; Lima-Junior JC; Daniel-Ribeiro CT; Pratt-Riccio LR
    Malar J; 2022 Jan; 21(1):6. PubMed ID: 34983540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Merozoite surface protein-1 epitopes recognized by antibodies that inhibit Plasmodium falciparum merozoite dispersal.
    Lyon JA; Carter JM; Thomas AW; Chulay JD
    Mol Biochem Parasitol; 1997 Dec; 90(1):223-34. PubMed ID: 9497045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasmodium falciparum MSP3 Exists in a Complex on the Merozoite Surface and Generates Antibody Response during Natural Infection.
    Deshmukh A; Chourasia BK; Mehrotra S; Kana IH; Paul G; Panda A; Kaur I; Singh SK; Rathore S; Das A; Gupta P; Kalamuddin M; Gakhar SK; Mohmmed A; Theisen M; Malhotra P
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29760216
    [No Abstract]   [Full Text] [Related]  

  • 29. Synthesis and evaluation of monoclonal antibody against Plasmodium falciparum merozoite surface antigen 2.
    Khosravi A; Asadollahy E; Ghafourian S; Sadeghifard N; Mohebi R
    Asian Pac J Trop Med; 2013 Oct; 6(10):798-803. PubMed ID: 23870469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal study of naturally acquired humoral immune responses against the merozoite surface protein 1 of Plasmodium vivax in patients from Rondonia, Brazil.
    Mertens F; Levitus G; Camargo LM; Ferreira MU; Dutra AP; Del Portillo HA
    Am J Trop Med Hyg; 1993 Sep; 49(3):383-92. PubMed ID: 8372960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fine specificity of serum antibodies to Plasmodium falciparum merozoite surface protein, PfMSP-1(19), predicts protection from malaria infection and high-density parasitemia.
    Okech BA; Corran PH; Todd J; Joynson-Hicks A; Uthaipibull C; Egwang TG; Holder AA; Riley EM
    Infect Immun; 2004 Mar; 72(3):1557-67. PubMed ID: 14977962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasmodium falciparum Protein Microarray Antibody Profiles Correlate With Protection From Symptomatic Malaria in Kenya.
    Dent AE; Nakajima R; Liang L; Baum E; Moormann AM; Sumba PO; Vulule J; Babineau D; Randall A; Davies DH; Felgner PL; Kazura JW
    J Infect Dis; 2015 Nov; 212(9):1429-38. PubMed ID: 25883384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Merozoite surface protein 2 allelic variation influences the specific antibody response during acute malaria in individuals from a Brazilian endemic area.
    Sallenave-Sales S; Faria CP; Zalis MG; Daniel-Ribeiro CT; Ferreira-da-Cruz Mde F
    Mem Inst Oswaldo Cruz; 2007 Jun; 102(3):421-4. PubMed ID: 17568950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody responses to Plasmodium falciparum sporozoite-, liver- and blood-stage synthetic peptides in migrant and autochthonous populations in malaria endemic areas.
    Ferreira-da-Cruz MF; Deslandes DC; Oliveira-Ferreira J; Montenegro-James S; Tartar A; Druilhe P; Daniel-Ribeiro CT
    Parasite; 1995 Mar; 2(1):23-9. PubMed ID: 9137641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acquisition of antibodies to merozoite surface protein 3 among residents of Korogwe, north eastern Tanzania.
    Segeja MD; Mmbando BP; Seth MD; Lusingu JP; Lemnge MM
    BMC Infect Dis; 2010 Mar; 10():55. PubMed ID: 20205959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria.
    Taylor RR; Allen SJ; Greenwood BM; Riley EM
    Am J Trop Med Hyg; 1998 Apr; 58(4):406-13. PubMed ID: 9574783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Individuals living in a malaria-endemic area of Cameroon do not have an acquired antibody response to Plasmodium falciparum histidine-rich protein 2.
    Taylor DW; Bobbili N; Khadka VS; Quakyi IA; Leke RG
    Malar J; 2017 Feb; 16(1):58. PubMed ID: 28148260
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibodies to the Plasmodium falciparum Proteins MSPDBL1 and MSPDBL2 Opsonize Merozoites, Inhibit Parasite Growth, and Predict Protection From Clinical Malaria.
    Chiu CY; Hodder AN; Lin CS; Hill DL; Li Wai Suen CS; Schofield L; Siba PM; Mueller I; Cowman AF; Hansen DS
    J Infect Dis; 2015 Aug; 212(3):406-15. PubMed ID: 25646353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serological markers for monitoring historical changes in malaria transmission intensity in a highly endemic region of Western Kenya, 1994-2009.
    Wong J; Hamel MJ; Drakeley CJ; Kariuki S; Shi YP; Lal AA; Nahlen BL; Bloland PB; Lindblade KA; Were V; Otieno K; Otieno P; Odero C; Slutsker L; Vulule JM; Gimnig JE
    Malar J; 2014 Nov; 13():451. PubMed ID: 25416454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence that invasion-inhibitory antibodies specific for the 19-kDa fragment of merozoite surface protein-1 (MSP-1 19) can play a protective role against blood-stage Plasmodium falciparum infection in individuals in a malaria endemic area of Africa.
    John CC; O'Donnell RA; Sumba PO; Moormann AM; de Koning-Ward TF; King CL; Kazura JW; Crabb BS
    J Immunol; 2004 Jul; 173(1):666-72. PubMed ID: 15210830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.